Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp
Get in touch
Download Visual

High-resolution images and Product visuals

Watch Video

Product overview and usage information

Read Literature

Detailed information and research documents

About the Product

Description

Restripe 60 Tablet contains Resmetirom 60mg, a targeted therapy for lipid and liver health management. It helps reduce liver fat accumulation and improve lipid metabolism, supporting patients with non-alcoholic fatty liver disease (NAFLD) and other metabolic liver disorders.

This tablet is gaining attention among prescribers due to its novel mechanism and efficacy, providing noticeable improvements in liver function and metabolic markers. Patients benefit from better liver health, improved cholesterol profiles, and enhanced long-term wellness.

For franchise partners, Restripe 60 Tablet is a high-demand product in the cardio-metabolic and liver care segment, offering strong market potential. Its advanced clinical relevance ensures repeat prescriptions and prescriber trust, making it a profitable addition to specialty portfolios.

With growing awareness of liver health and metabolic disorders, Restripe 60 Tablet provides sustainable sales opportunities, helping partners establish a strong presence in the lipid and liver care segment while expanding business reach.

Common side effects may include mild headache, fatigue, nausea, diarrhea, or transient changes in liver enzyme levels. Some patients may experience palpitations or insomnia. Any severe, persistent, or unusual symptoms should be reported immediately to a healthcare professional.

Restripe 60 Tablet is indicated for the treatment of non-alcoholic steatohepatitis (NASH) and associated dyslipidemia in adults. It is used to reduce hepatic fat content, improve lipid metabolism, and support liver function in patients at risk of progressive liver disease.

Restripe 60 Tablet should be taken as prescribed and not used in patients with severe liver dysfunction or hypersensitivity to Resmetirom. Regular monitoring of liver function tests and lipid profile is recommended during therapy. Inform your doctor about other medications or underlying health conditions before starting treatment.

Store Restripe 60 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the pack.

Get in Touch

Similar Products

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Resmetirom 60mg Tablet in the PCD pharma franchise market?

Resmetirom 60mg Tablet has strong emerging demand in the specialty hepatology and metabolic liver disease segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on liver care and chronic metabolic disorder portfolios.

Why should medical distributors include Resmetirom 60mg Tablet in their product range?

Medical distributors and agencies can benefit from increasing clinical focus on non-alcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatotic liver disease (MASLD/MAFLD) under specialist supervision. Resmetirom 60mg is a thyroid hormone receptor-beta (THR-β) agonist Helps reduce liver fat accumulation and supports improvement in metabolic liver function Used in specialist hepatology and metabolic disease management protocols This strengthens a niche but high-value specialty liver-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Resmetirom 60mg Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Resmetirom 60mg Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from growing demand in hepatology clinics, emerging NAFLD/NASH treatment market, long-term therapy usage, institutional prescriptions, reliable supply chain support, and strong margins in specialty liver medicines.

How can I become a distributor or franchise partner for Resmetirom 60mg Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited

Links

Contact Us

+91 9518447302
info@cafoli.in
Plot No. 367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

Let's Socialize

Professional B2B Disclaimer: This website is a Business-to-Business (B2B) platform intended exclusively for pharmaceutical traders, distributors, wholesalers, and healthcare professionals. The information provided—including product compositions, therapeutic categories, and portfolios—is for commercial and educational reference only. It is not intended for consumers or as a substitute for professional medical advice, diagnosis, or treatment. Cafoli Lifecare does not sell medicines directly to individuals. All trade inquiries are subject to valid drug license verification.

@2024 | copy rights by Cafoli